US equities |
MU $1,048.68 ▼-1.54% NVDA $229.28 ▲+0.39% SNDK $1,740.43 ▲+0.03% TSLA $357.09 ▲+0.64% INTC $119.58 ▼-0.54% AMD $612.03 ▲+0.04% GOOGL $340.11 ▼-1.15% SPCX $150.61 ▼-0.17%
FinancialContent Watchlist

Articles published by Insulet Corporation

< Previous 1 2 3 4 Next >
News headline image
Insulet to Announce Third Quarter 2026 Financial Results on November 4, 2026
From Insulet Corporation
Via Business Wire
Tickers PODD
News headline image
Insulet to Participate in Bernstein Insights: Healthcare Leaders and Disruptors – 3rd Annual Healthcare Forum
From Insulet Corporation
Via Business Wire
Tickers PODD
News headline image
Insulet to Participate in Wells Fargo 21st Annual Healthcare Conference
From Insulet Corporation
Via Business Wire
Tickers PODD
News headline image
Insulet Reports Second Quarter 2026 Results
From Insulet Corporation
Via Business Wire
Tickers PODD
News headline image
Insulet Partners with Calm to Bring Mindfulness and Well-Being Tools to the Diabetes Community, Featuring a New Sleep Story Narrated by Lila Moss
From Insulet Corporation
Via Business Wire
Tickers PODD
News headline image
Insulet Accelerates Global Growth with Launch of Omnipod® 5 and Omnipod Discover™ in Spain, Expanding Access to Tubeless Diabetes Technology
From Insulet Corporation
Via Business Wire
Tickers PODD
News headline image
Insulet to Announce Second Quarter 2026 Financial Results on August 5, 2026
From Insulet Corporation
Via Business Wire
Tickers PODD
News headline image
Insulet Announces Appointment of Jonathan J. Mazelsky to its Board of Directors
From Insulet Corporation
Via Business Wire
Tickers PODD
News headline image
Insulet Reveals New Data Supporting Breakthrough Omnipod® 6 and Fully Closed-Loop AID Systems Designed to Improve Outcomes, Reduce Effort, and Unlock Barriers to Care
From Insulet Corporation
Via Business Wire
Tickers PODD
News headline image
Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessions
From Insulet Corporation
Via Business Wire
Tickers PODD
News headline image
Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility with Abbott’s FreeStyle Libre 3 Plus Sensor
From Insulet Corporation
Via Business Wire
Tickers PODD
News headline image
Insulet to Participate in William Blair 46th Annual Growth Stock Conference
From Insulet Corporation
Via Business Wire
Tickers PODD
News headline image
Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® Pods in the U.S. and Affected International Markets
From Insulet Corporation
Via Business Wire
Tickers PODD
News headline image
Insulet Reports First Quarter 2026 Results
From Insulet Corporation
Via Business Wire
Tickers PODD
News headline image
Insulet Unveils 2025 Sustainability Report Highlighting Strong Momentum Across Key Priorities
From Insulet Corporation
Via Business Wire
Tickers PODD
News headline image
Insulet Initiates EVOLVE Pivotal Study to Advance Fully Closed-Loop Automated Insulin Delivery System for Type 2 Diabetes
From Insulet Corporation
Via Business Wire
Tickers PODD
News headline image
Insulet to Participate in BofA Securities 2026 Health Care Conference
From Insulet Corporation
Via Business Wire
Tickers PODD
News headline image
Insulet to Announce First Quarter 2026 Financial Results on May 6, 2026
From Insulet Corporation
Via Business Wire
Tickers PODD
News headline image
Insulet Appoints Mike Panos as Chief Commercial Officer
From Insulet Corporation
Via Business Wire
Tickers PODD
News headline image
Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 Diabetes
From Insulet Corporation
Via Business Wire
Tickers PODD
News headline image
Insulet to Present EVOLUTION 2 Results on Omnipod® Fully Closed-Loop System for Adults with Type 2 Diabetes at International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
From Insulet Corporation
Via Business Wire
Tickers PODD
News headline image
Insulet Reports Fourth Quarter and Full Year 2025 Results
From Insulet Corporation
Via Business Wire
Tickers PODD
News headline image
Insulet Launches Omnipod® 5 and Omnipod Discover™ in the Middle East to Transform Diabetes Care
From Insulet Corporation
Via Business Wire
Tickers PODD
News headline image
Insulet Redefines Diabetes at CES with "Liveable Technology" — A New Frontier in Human-Centered Connected Health
From Insulet Corporation
Via Business Wire
Tickers PODD
News headline image
Insulet to Participate in 44th Annual J.P. Morgan Healthcare Conference
From Insulet Corporation
Via Business Wire
Tickers PODD
News headline image
Insulet Expands Omnipod® U.S. Recycling Program, Diverting Millions of Pods from Landfills and Creating a More Sustainable Future
From Insulet Corporation
Via Business Wire
Tickers PODD
News headline image
Insulet Announces FDA 510(k) Clearance of Omnipod® 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience
From Insulet Corporation
Via Business Wire
Tickers PODD
News headline image
Insulet Outlines Long-Term Strategy to Drive Growth and Value Creation at 2025 Investor Day
From Insulet Corporation
Via Business Wire
Tickers PODD
News headline image
Insulet Reports Third Quarter 2025 Results
From Insulet Corporation
Via Business Wire
Tickers PODD
News headline image
Insulet Champions Workplace Inclusion for People with Diabetes with New Data and Tools Released for Diabetes Awareness Month
From Insulet Corporation
Via Business Wire
Tickers PODD
< Previous 1 2 3 4 Next >